Filters
Other countries
Results: 1 to 15 of 15
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
DRAM2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
Invitae Macular Dystrophy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 66 | 36 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Inherited Retinal Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 486 | 293 |
|
Cone-Rod Dystrophy via the DRAM2 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Molecular Vision Laboratory United States | 342 | 268 |
|
PreventionGenetics, part of Exact Sciences United States | 37 | 35 |
|
Macular dystrophy panel. NGS panel of 26 genes. Genologica Medica Spain | 50 | 26 |
|
Retinal dystrophy panel. 260 gene NGS panel. Genologica Medica Spain | 420 | 257 |
|
Cone-rod dystrophy/Cone dystrophy: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 24 | 22 |
|
Macular Degeneration NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 26 | 24 |
|
Molecular Vision Laboratory United States | 379 | 287 |
|
Molecular Vision Laboratory United States | 28 | 13 |
|
Results: 1 to 15 of 15
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.